List of works - Orhan Aktaş

Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress

scientific article

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

scientific article published in 2012

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

scientific article published on November 23, 2013

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

scientific article published on August 2006

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

scientific article

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

scientific article

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

scientific article

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

scientific article published on 26 September 2016

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

scientific article

Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.

scientific article published on 5 April 2012

Neuronal damage in brain inflammation

scientific article published on February 2007

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

scientific article

Optical coherence tomography in parkinsonian syndromes

scientific article

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

scientific article

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis

scientific article

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system

scientific article

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

scientific article

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

scientific article

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain

scientific article (publication date: 15 February 2002)

Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage

scientific article

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

scientific article published on July 1, 2015

IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity

scientific article

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis

scientific article published on 2 February 2016

Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation

scientific article

Impact of HMG-CoA reductase inhibition on brain pathology

scientific article published on 15 June 2007

Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1.

scientific article

Update on biomarkers in neuromyelitis optica

scientific article (publication date: August 2015)

Natalizumab restores aberrant miRNAexpression profile in multiple sclerosis and reveals a critical role for miR‐20b

scientific article published on December 5, 2014

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

scientific article

The role of TRAIL/TRAIL receptors in central nervous system pathology

scientific article published on May 2007

Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study

scientific article

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

scientific article

Diagnostic criteria for Susac syndrome

scientific article

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

scientific article published on June 2017

Premature aging of the hippocampal neurogenic niche in adult Bmal1-deficient mice

scientific article published in June 2015

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Development of oral cladribine for the treatment of multiple sclerosis

scientific article

Death ligands and autoimmune demyelination

scientific article published on August 2006

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany

scientific article

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

scientific article published on 25 January 2016

Retinal Neurodegeneration in Wilson’s Disease Revealed by Spectral Domain Optical Coherence Tomography

scientific article published on November 16, 2012

Visual evoked potentials in neuromyelitis optica and its spectrum disorders

scientific article published on 5 September 2013

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

scientific article

Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol

scientific article published on March 2016

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets

scientific article published on 10 January 2007

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

scientific article published on 10 May 2015

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

scientific article published on January 1, 2016

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

scientific article

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

scientific article

Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab

scientific article published on December 17, 2014

List of works by Orhan Aktaş

Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.

Neuronal damage in brain inflammation

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

Optical coherence tomography in parkinsonian syndromes

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain

Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis

Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation

Impact of HMG-CoA reductase inhibition on brain pathology

Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1.

Update on biomarkers in neuromyelitis optica

Natalizumab restores aberrant miRNAexpression profile in multiple sclerosis and reveals a critical role for miR‐20b

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

The role of TRAIL/TRAIL receptors in central nervous system pathology

Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

Diagnostic criteria for Susac syndrome

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Premature aging of the hippocampal neurogenic niche in adult Bmal1-deficient mice

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

Development of oral cladribine for the treatment of multiple sclerosis

Death ligands and autoimmune demyelination

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

Retinal Neurodegeneration in Wilson’s Disease Revealed by Spectral Domain Optical Coherence Tomography

Visual evoked potentials in neuromyelitis optica and its spectrum disorders

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS.

Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab